Paper19750010
O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.
Zhang X and 2 others. PLoS One, 2009. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. Papers, record 19750010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19750010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies | Major topic |
| Bordetella parapertussis | Major topic |
| Bordetella pertussis | Major topic |
| O Antigens | Major topic |
| Pertussis Vaccine | Major topic |
| Animals | |
| Bordetella Infections | |
| Interferon-gamma | |
| Leukocytes, Mononuclear | |
| Lung | |
| Mice | |
| Mice, Inbred C57BL | |
| Phagocytosis | |
| Protein Binding | |
| Spleen |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI053075 | NIAID NIH HHS | United States | R01AI053075 | PubMed and NIH | NIH RePORTER |
| R01 GM083113 | NIGMS NIH HHS | United States | R01GM083113 | PubMed and NIH | NIH RePORTER |
| GM083113 | NIGMS NIH HHS | United States | R01GM083113 | PubMed and NIH | NIH RePORTER |
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17210665 | Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. | Infect Immun | 2007 | https://conductscience.org/library/papers/17210665 | PubMed |
| 2 | 2906641 | Use of supplemented Stainer-Scholte broth for the isolation of Bordetella pertussis from clinical material. | J Clin Microbiol | 1988 | https://conductscience.org/library/papers/2906641 | PubMed |
| 3 | 9607064 | The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model. | Vaccine | 1998 | https://conductscience.org/library/papers/9607064 | PubMed |
| 4 | 15831828 | Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. | Clin Microbiol Rev | 2005 | https://conductscience.org/library/papers/15831828 | PubMed |
| 5 | 9542925 | Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates. | J Clin Microbiol | 1998 | https://conductscience.org/library/papers/9542925 | PubMed |
| 6 | 16382131 | Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. | Pediatrics | 2006 | https://conductscience.org/library/papers/16382131 | PubMed |
| 7 | 16428751 | The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. | Infect Immun | 2006 | https://conductscience.org/library/papers/16428751 | PubMed |
| 8 | 9382883 | Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. | J Exp Med | 1997 | https://conductscience.org/library/papers/9382883 | PubMed |
| 9 | 11334963 | Flow cytometry-based phagocytosis assay for sensitive detection of opsonic activity of pneumococcal capsular polysaccharide antibodies in human sera. | J Immunol Methods | 2001 | https://conductscience.org/library/papers/11334963 | PubMed |
| 10 | 7475771 | Pertussis in adults: frequency of transmission after household exposure. | Lancet | 1995 | https://conductscience.org/library/papers/7475771 | PubMed |
| 11 | 18285500 | O antigen protects Bordetella parapertussis from complement. | Infect Immun | 2008 | https://conductscience.org/library/papers/18285500 | PubMed |
| 12 | 16557217 | Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). | MMWR Recomm Rep | 2006 | https://conductscience.org/library/papers/16557217 | PubMed |
| 13 | 12654784 | Role of antibodies in immunity to Bordetella infections. | Infect Immun | 2003 | https://conductscience.org/library/papers/12654784 | PubMed |
| 14 | 11871441 | From the Centers for Disease Control and Prevention. Pertussis--United States, 1997-2000. | JAMA | 2002 | https://conductscience.org/library/papers/11871441 | PubMed |
| 15 | 11714823 | Fc receptor-mediated immunity against Bordetella pertussis. | J Immunol | 2001 | https://conductscience.org/library/papers/11714823 | PubMed |
| 16 | 16177324 | Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity. | Infect Immun | 2005 | https://conductscience.org/library/papers/16177324 | PubMed |
| 17 | 1714327 | Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. | Blood | 1991 | https://conductscience.org/library/papers/1714327 | PubMed |
| 18 | 3584073 | Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. | J Bacteriol | 1987 | https://conductscience.org/library/papers/3584073 | PubMed |
| 19 | 10417135 | Genetic basis for lipopolysaccharide O-antigen biosynthesis in bordetellae. | Infect Immun | 1999 | https://conductscience.org/library/papers/10417135 | PubMed |
| 20 | 4324651 | A simple chemically defined medium for the production of phase I Bordetella pertussis. | J Gen Microbiol | 1970 | https://conductscience.org/library/papers/4324651 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38543887 | Pertussis Vaccines Scarcely Provide Protection against Bordetella parapertussis Infection in Children-A Systematic Review and Meta-Analysis. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38543887 | PubMed |
| 38011105 | Adenylate cyclase toxin of Bordetella parapertussis disrupts the epithelial barrier granting the bacterial access to the intracellular space of epithelial cells. | PLoS One | 2023 | https://conductscience.org/library/papers/38011105 | PubMed |
| 33178148 | Evolution and Conservation of Bordetella Intracellular Survival in Eukaryotic Host Cells. | Front Microbiol | 2020 | https://conductscience.org/library/papers/33178148 | PubMed |
| 31889098 | Enhancement of immune response against Bordetella spp. by disrupting immunomodulation. | Sci Rep | 2019 | https://conductscience.org/library/papers/31889098 | PubMed |
| 31744907 | Conserved Patterns of Symmetric Inversion in the Genome Evolution of Bordetella Respiratory Pathogens. | mSystems | 2019 | https://conductscience.org/library/papers/31744907 | PubMed |
| 31190311 | Bordetella bronchiseptica Glycosyltransferase Core Mutants Trigger Changes in Lipid A Structure. | J Am Soc Mass Spectrom | 2019 | https://conductscience.org/library/papers/31190311 | PubMed |
| 30976607 | Bordetella parapertussis Bacteremia: Clinical Expression and Bacterial Genomics. | Open Forum Infect Dis | 2019 | https://conductscience.org/library/papers/30976607 | PubMed |
| 30459769 | Outer-Membrane-Vesicle-Associated O Antigen, a Crucial Component for Protecting Against Bordetella parapertussis Infection. | Front Immunol | 2018 | https://conductscience.org/library/papers/30459769 | PubMed |
| 28514288 | Bordetella parapertussis outbreak in Southeastern Minnesota and the United States, 2014. | Medicine (Baltimore) | 2017 | https://conductscience.org/library/papers/28514288 | PubMed |
| 28095485 | Bordetella parapertussis Circumvents Neutrophil Extracellular Bactericidal Mechanisms. | PLoS One | 2017 | https://conductscience.org/library/papers/28095485 | PubMed |
| 27716057 | Acquisition and loss of virulence-associated factors during genome evolution and speciation in three clades of Bordetella species. | BMC Genomics | 2016 | https://conductscience.org/library/papers/27716057 | PubMed |
| 25422302 | Bordetella parapertussis PagP mediates the addition of two palmitates to the lipopolysaccharide lipid A. | J Bacteriol | 2015 | https://conductscience.org/library/papers/25422302 | PubMed |
| 25267839 | Bordetella parapertussis survives inside human macrophages in lipid raft-enriched phagosomes. | Infect Immun | 2014 | https://conductscience.org/library/papers/25267839 | PubMed |
| 23092514 | Lack of cross-protection against Bordetella holmesii after pertussis vaccination. | Emerg Infect Dis | 2012 | https://conductscience.org/library/papers/23092514 | PubMed |
| 23027528 | Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen. | Infect Immun | 2012 | https://conductscience.org/library/papers/23027528 | PubMed |
| 21398615 | Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice. | J Immunol | 2011 | https://conductscience.org/library/papers/21398615 | PubMed |
| 20974829 | Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis. | Infect Immun | 2011 | https://conductscience.org/library/papers/20974829 | PubMed |
| 20592026 | Antigenic Variation among Bordetella: Bordetella bronchiseptica strain MO149 expresses a novel o chain that is poorly immunogenic. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20592026 | PubMed |
| 20200027 | Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis. | Proc Biol Sci | 2010 | https://conductscience.org/library/papers/20200027 | PubMed |
| 19737902 | The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis. | Infect Immun | 2009 | https://conductscience.org/library/papers/19737902 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19750010
GET https://conductscience.org/api/papers/v1/19750010/references?page=2